| CLI vs |
Subgroup (n) |
Odds ratios (OR) (95% Confidence intervals) |
| Unadjusted |
p value |
Adjusted* |
p value |
| Smoking |
HIV- (192) |
10.70 (7.16-15.83) |
<0.0001 |
10.12 (6.01-17.08) |
<0.0001 |
| |
HIV-<60 yrs (64) |
10.90 (6.09-19.52) |
<0.0001 |
7.75 (4.12-14.55) |
<0.0001 |
| |
HIV-≥60 yrs (128) |
10.52 (6.72-16.49) |
<0.0001 |
12.84 (6.74-24.47) |
<0.0001 |
| Hypertension |
HIV- (192) |
2.60 (1.82-3.72) |
<0.0001 |
0.76 (0.47-1.21) |
=0.50 |
| |
HIV-<60 yrs (64) |
1.93 (1.13-3.31) |
<0.05 |
1.15 (0.62-2.13) |
=0.06 |
| |
HIV-≥60 yrs (128) |
3.05 (1.99-4.69) |
<0.0001 |
0.44 (0.25-0.79) |
<0.05 |
| |
HIV+ (25) |
0.24 (0.08-0.70) † |
<0.0001 |
0.12 (0.04-0.40) † |
<0.01 |
| DM |
HIV- (192) |
9.82 (6.36-15.16) |
<0.0001 |
6.71 (4.0-11.3) |
<0.0001 |
| |
HIV-<60 yrs (64) |
12.89 (7.12-23.53) |
<0.0001 |
15.06 (7.41-30.60) |
<0.0001 |
| |
HIV-≥60 yrs (128) |
8.57 (5.31-13.84) |
<0.0001 |
3.93 (2.10-7.14) |
<0.0001 |
| |
HIV+ (25) |
0.87 (0.20-3.84) † |
=0.86 |
0.95 (0.20-4.54 |
=0.60 |
| Increased TG |
HIV- (192) |
1.56 (1.03-2.37) |
<0.05 |
0.88 (0.54-1.43) |
=0.59 |
| |
HIV-<60 yrs (64) |
2.47 (1.38-4.43) |
<0.005 |
1.91 (1.02-3.58) |
<0.05 |
| |
HIV-≥60 yrs (128) |
1.19 (0.72-1.98) |
=0.49 |
0.47 (0.26-0.86) |
<0.05 |
| |
HIV+ (25) |
0.69 (0.20-2.37) |
=0.55 |
0.53 (0.15-1.92) |
=0.28 |
| Decreased HDL cholest |
HIV- (192) |
3.17 (2.18-4.59) |
<0.0001 |
3.73 (2.34-5.95) |
<0.0001 |
| |
HIV-<60 yrs (64) |
4.37 (2.50-7.63) |
< 0.0001 |
5.81 (3.11-10.86) |
<0.0001 |
| |
HIV-≥60 yrs (128) |
2.69 (1.76-4.13) |
<0.0001 |
2.66 (1.54-4.60) |
=0.001 |
| |
HIV+ (25) |
2.75 (1.17-6.47) |
<0.05 |
3.76 (1.51-9.36) |
<0.01 |
DM- Diabetes Mellitus; TG- Tryglycerides; HDL cholest- High Density Lipoprotein Fraction of Cholesterol. *Age and sex-adjusted. Probability values were further adjusted
for non-independence of family members. Increased TG indicates values ≥ 1.7 mmol/l. Decreased HDL cholesterol indicates values <1.0 mmol/l for males and <1.2 mmol/l
for females. †p<0.001 vs OR for HIV- group. |
